Research Roundup


Debbie Rigby takes a look at the latest in research news

Understanding Cholesterol Therapy: An Update for Community Pharmacists

Elevated total and LDL cholesterol predispose patients to an increased risk of cardiovascular disease and mortality. An extensive amount of research supports the use of statins for secondary prevention. Myalgia remains the most commonly reported adverse effect with statins. New-onset diabetes has also been observed in clinical trials, but more commonly in patients with increased diabetes risk. The negative effects of statins on memory and cognition have been noted anecdotally in many case reports but have not been substantiated in larger trials.

US Pharm. 2019;44(2):16-24.

 

Recommending Aspirin for Primary Prevention of Cardiovascular Disease

The benefit of aspirin use for secondary prevention of cardiovascular disease is well established; the efficacy of aspirin use for primary prevention, however, is less evident. High-risk populations, such as patients with diabetes and those with a 10-year cardiovascular risk exceeding 10%, may benefit from low-dose aspirin primary prevention.

US Pharm. 2016;41(2):22-25.

 

Expanding the role of Australian pharmacists in community pharmacies in chronic pain management

This  review aimed  to  investigate  and  explore pharmacist-driven chronic pain educational and medication management interventions in community pharmacies on an international level,  and  thereby  identify  if  there  are  potential  benefits  in  modelling  and  incorporating  these  interventions  in  the  Australian community. Results demonstrated that there were improvements in the pain scores, depression/anxiety scales and physical functionality in patient groups receiving the pharmacist driven-interventions,  thereby  highlighting  the  clinical  benefit  of  these  interventions  in  chronic  pain.

Pharmacy Practice 2019;17(1):1410.

 

Awareness and use of medication management services in relation to medication adherence prior to hospitalisation among older adults in Regional Australia

A study conducted at the Maryborough hospital, Queensland with 198 patients showed hospitalised patients are unaware of medication management services ((MedsCheck, Diabetes MedsCheck and Home Medication Review) that could reduce frequency of re-hospitalisation. The authors concluded that community and hospital pharmacists can play a major role increasing patients’ awareness of the availability of these services.

International Journal of Clinical Pharmacy 2019;41(1):189-97.

Previous GP disqualified after drug, professional misconduct charges
Next AJP chats with... Flannery’s Pharmacy Forbes

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.